{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:51:03Z","timestamp":1794642663031,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hodgkin lymphoma is a lymphatic malignancy commonly found in cervical lymph nodes. This study evaluated the worldwide incidence, mortality, associated risk factors, and temporal trends of Hodgkin lymphoma by sex, age, and country.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The age-standardised Hodgkin lymphoma incidence and mortality were retrieved from the <jats:italic>GLOBOCAN<\/jats:italic>, <jats:italic>CI5<\/jats:italic> volumes I-XI, <jats:italic>WHO mortality database<\/jats:italic>, the <jats:italic>NORDCAN and SEER Program<\/jats:italic>. The age-standardised prevalence of smoking, alcohol drinking, obesity, and hypertension was also extracted for each country. Trends were tested using Average Annual Percentage Change (AAPC) from Joinpoint regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The Hodgkin lymphoma incidence and mortality were 0.98 and 0.26 per 100,000 in 2020. A higher incidence was observed in high-income countries, while higher mortality was found in low-income countries. Incidence and mortality were associated with GDP per capita, prevalence of smoking, obesity, and hypertension at the population level. Despite the decreasing mortality trend, there was an increasing incidence, especially among females, younger population, and subjects from Asian countries.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There was an increasing trend in Hodgkin lymphoma incidence, especially among subjects who were female, younger population, and from Asian countries. Further studies are needed to investigate the reasons for these epidemiologic trends.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13045-022-01281-9","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T14:03:30Z","timestamp":1652277810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":147,"title":["Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Junjie","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Sze","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeleah","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Don Eliseo","family":"Lucero-Prisno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanghong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmar","family":"Elcarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellissa","family":"Withers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C. S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"NCD Global Health Research Group, Association of Pacific Rim Universities (APRU)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"1281_CR1","unstructured":"Kaseb H, Babiker HM. Hodgkin lymphoma. Updated June 30, 2021. Accessed 21 Feb 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499969\/."},{"issue":"3","key":"1281_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1281_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.semradonc.2009.09.006","volume":"20","author":"A Punnett","year":"2010","unstructured":"Punnett A, Tsang RW, Hodgson DC. Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects. Semin Radiat Oncol. 2010;20(1):30\u201344. https:\/\/doi.org\/10.1016\/j.semradonc.2009.09.006.","journal-title":"Semin Radiat Oncol"},{"issue":"6","key":"1281_CR4","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/bjh.15789","volume":"185","author":"ML Metzger","year":"2019","unstructured":"Metzger ML, Mauz-K\u00f6rholz C. Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin lymphoma. Br J Haematol. 2019;185(6):1142\u201357. https:\/\/doi.org\/10.1111\/bjh.15789.","journal-title":"Br J Haematol"},{"issue":"8","key":"1281_CR5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s12094-018-02032-4","volume":"21","author":"A Amraee","year":"2019","unstructured":"Amraee A, Evazi MR, Shakeri M, et al. Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed\/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study. Clin Transl Oncol. 2019;21(8):1093\u2013103. https:\/\/doi.org\/10.1007\/s12094-018-02032-4.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"1281_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s1040-8428(00)00046-9","volume":"34","author":"JL Hsu","year":"2000","unstructured":"Hsu JL, Glaser SL. Epstein\u2013Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol. 2000;34(1):27\u201353. https:\/\/doi.org\/10.1016\/s1040-8428(00)00046-9.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"1281_CR7","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","volume":"108","author":"RJ Biggar","year":"2006","unstructured":"Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS. J Blood. 2006;108(12):3786\u201391. https:\/\/doi.org\/10.1182\/blood-2006-05-024109.","journal-title":"J Blood"},{"issue":"18","key":"1281_CR8","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/jnci\/djj361","volume":"98","author":"O Landgren","year":"2006","unstructured":"Landgren O, Engels EA, Pfeiffer RM, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst. 2006;98(18):1321\u201330. https:\/\/doi.org\/10.1093\/jnci\/djj361.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"1281_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10552-021-01446-w","volume":"32","author":"T Taj","year":"2021","unstructured":"Taj T, Poulsen AH, Ketzel M, et al. Long-term residential exposure to air pollution and Hodgkin lymphoma risk among adults in Denmark: a population-based case\u2013control study. Cancer Causes Control. 2021;32(9):935\u201342. https:\/\/doi.org\/10.1007\/s10552-021-01446-w.","journal-title":"Cancer Causes Control"},{"key":"1281_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780190676827.003.0026","author":"H Hjalgrim","year":"2018","unstructured":"Hjalgrim H, Melbye M, Lagiou P. Hodgkin lymphoma. Textbook Cancer Epidemiol. 2018. https:\/\/doi.org\/10.1093\/oso\/9780190676827.003.0026.","journal-title":"Textbook Cancer Epidemiol"},{"key":"1281_CR11","unstructured":"International Agency for Research on Cancer WHO. Data visualization tools for exploring the global cancer burden in 2020. 2020. Accessed 2 Feb 2022. https:\/\/gco.iarc.fr\/today\/home."},{"key":"1281_CR12","unstructured":"United Nations. Human development classification, 2018 Statistical update; 2018. Accessed 2 Feb 2022. http:\/\/hdr.undp.org\/sites\/default\/files\/2018_human_development_statistical_update.pdf."},{"key":"1281_CR13","unstructured":"World Health Organization. Global Health Observatory data repository; 2016. Accessed 2 Feb 2022. https:\/\/apps.who.int\/gho\/data\/node.main."},{"key":"1281_CR14","unstructured":"Bray FCMML, Pi\u00f1eros M, Znaor A, Zanetti R, Ferlay J, editors. Cancer incidence in five continents, Vol. XI (electronic version) Lyon: International Agency for Research on Cancer. 2017. Accessed 4 Feb 2022. https:\/\/ci5.iarc.fr."},{"key":"1281_CR15","unstructured":"World Health Organization. WHO mortality database. 2020. Accessed 4 Feb 2022. https:\/\/www.who.int\/healthinfo\/mortality_data\/en\/."},{"key":"1281_CR16","unstructured":"Danckert BFJEG, Hansen HL, Johannesen TB, Khan S, K\u00f8tlum JE, \u00d3lafsd\u00f3ttir E, Schmidt LKH, Virtanen A, Storm HH,. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries, Version 8.2 (26.03.2019); 2019. Accessed 4 Feb 2022. https:\/\/www-dep.iarc.fr\/NORDCAN\/english\/frame.asp."},{"issue":"5","key":"1281_CR17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3109\/02841861003782017","volume":"49","author":"GFJ Engholm","year":"2010","unstructured":"Engholm GFJ, Christensen N, et al. NORDCAN\u2014a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725\u201336. https:\/\/doi.org\/10.3109\/02841861003782017.","journal-title":"Acta Oncol"},{"key":"1281_CR18","unstructured":"U.S. Department of Health and Human Services NIoH. Surveillance, Epidemiology, and End Results (SEER) Program. 2020. Accessed 4 Feb 2022. https:\/\/seer.cancer.gov\/about\/."},{"issue":"3","key":"1281_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351. https:\/\/doi.org\/10.1002\/(sici)1097-0258(20000215)19:3%3c335::aid-sim336%3e3.0.co;2-z.","journal-title":"Stat Med"},{"issue":"1","key":"1281_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","volume":"12","author":"L Zhou","year":"2019","unstructured":"Zhou L, Deng Y, Li N, et al. Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study. J Hematol Oncol. 2019;12(1):107. https:\/\/doi.org\/10.1186\/s13045-019-0799-1.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"1281_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s0145-2126(01)00126-6","volume":"26","author":"SL Glaser","year":"2002","unstructured":"Glaser SL, Hsu JL. Hodgkin\u2019s disease in Asians: incidence patterns and risk factors in population-based data. Leuk Res. 2002;26(3):261\u20139. https:\/\/doi.org\/10.1016\/s0145-2126(01)00126-6.","journal-title":"Leuk Res"},{"issue":"2","key":"1281_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.critrevonc.2012.07.002","volume":"85","author":"PG Gobbi","year":"2013","unstructured":"Gobbi PG, Ferreri AJM, Ponzoni M, et al. Hodgkin lymphoma. Crit Rev Oncol Hematol. 2013;85(2):216\u201337. https:\/\/doi.org\/10.1016\/j.critrevonc.2012.07.002.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"1281_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1365-2796.2008.02031.x","volume":"264","author":"H Hjalgrim","year":"2008","unstructured":"Hjalgrim H, Engels EA. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med. 2008;264(6):537\u201348. https:\/\/doi.org\/10.1111\/j.1365-2796.2008.02031.x.","journal-title":"J Intern Med"},{"key":"1281_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/annonc\/13.S1.23","volume":"13","author":"RF Jarrett","year":"2002","unstructured":"Jarrett RF. Viruses and Hodgkin\u2019s lymphoma. Ann Oncol. 2002;13:23\u20139. https:\/\/doi.org\/10.1093\/annonc\/13.S1.23.","journal-title":"Ann Oncol"},{"issue":"9","key":"1281_CR25","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/annonc\/mdt218","volume":"24","author":"M Kamper-J\u00f8rgensen","year":"2013","unstructured":"Kamper-J\u00f8rgensen M, Rostgaard K, Glaser SL, et al. Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Ann Oncol. 2013;24(9):2245\u201355. https:\/\/doi.org\/10.1093\/annonc\/mdt218.","journal-title":"Ann Oncol"},{"issue":"7","key":"1281_CR26","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41416-019-0401-1","volume":"120","author":"H Strongman","year":"2019","unstructured":"Strongman H, Brown A, Smeeth L, et al. Body mass index and Hodgkin\u2019s lymphoma: UK population-based cohort study of 5.8 million individuals. Brit J Cancer. 2019;120(7):768\u201370. https:\/\/doi.org\/10.1038\/s41416-019-0401-1.","journal-title":"Brit J Cancer"},{"issue":"1","key":"1281_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/01.ede.0000248899.47399.78","volume":"18","author":"EV Willett","year":"2007","unstructured":"Willett EV, O\u2019Connor S, Smith AG, et al. Does smoking or alcohol modify the risk of Epstein\u2013Barr virus-positive or -negative Hodgkin lymphoma? Epidemiology. 2007;18(1):130\u20136. https:\/\/doi.org\/10.1097\/01.ede.0000248899.47399.78.","journal-title":"Epidemiology"},{"issue":"9945","key":"1281_CR28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384(9945):766\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(14)60460-8.","journal-title":"The Lancet"},{"key":"1281_CR29","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/S0140-6736(18)32643-6","volume":"392","author":"J Huang","year":"2018","unstructured":"Huang J, Huang JLW, Withers M, et al. Prevalence of metabolic syndrome in Chinese women and men: a systematic review and meta-analysis of data from 734\u2008511 individuals. The Lancet. 2018;392:S14. https:\/\/doi.org\/10.1016\/S0140-6736(18)32643-6.","journal-title":"The Lancet"},{"issue":"7","key":"1281_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10654-020-00650-3","volume":"35","author":"MCS Wong","year":"2020","unstructured":"Wong MCS, Huang J, Wang J, et al. Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects. Eur J Epidemiol. 2020;35(7):673\u201383. https:\/\/doi.org\/10.1007\/s10654-020-00650-3.","journal-title":"Eur J Epidemiol"},{"issue":"35","key":"1281_CR31","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1200\/jco.2016.69.4638","volume":"34","author":"MA Onstad","year":"2016","unstructured":"Onstad MA, Schmandt RE, Lu KH. Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol. 2016;34(35):4225\u201330. https:\/\/doi.org\/10.1200\/jco.2016.69.4638.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-022-01281-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-022-01281-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-022-01281-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T14:05:25Z","timestamp":1652277925000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-022-01281-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1281"],"URL":"https:\/\/doi.org\/10.1186\/s13045-022-01281-9","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"23 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Survey and Behavioural Research Ethics Committee, the Chinese University of Hong Kong (No. SBRE-20-332). The study only used publicly available databases, and informed consent is waived by the Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study only used publicly available databases which provided the consent for use and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}